News Express

尔康集团顺利通过八家客户的年度审计new

日前,以美国强生药业子公司、曼秀雷敦(中国)药业有限公司、台湾永信药品公司为代表的8家中外大中型制药公司前来尔康集团,对公司开展了年度供应商审计工作。经过为期数...

尔康制药在浏阳市举办的“诚信纳税”演讲赛中荣获第new

5月27日,由浏阳市财政局、地税局、国税局共同举办的"诚信纳税 奉献社会"演讲比赛在浏阳市广电中心顺利落幕。由尔康制药人力资源部选送的选手王领,在众多专业选手中...

尔康淀粉胶囊在中东市场首战告捷new

5月10日,随着由巴黎飞往特拉维夫的航班平稳降落于本古里安机场,尔康国际事业部海外营销总监王楠带领的公司销售团队开启了为期3天的展会工作。这是尔康淀粉胶囊进入中...

Product order

Enter

Video Center

More

Core business

More
  • Current Pharmaceutical Ex.... Conventional pharmaceutical excipients and new-type pharmaceutical excipients: Er-Kang produces more than 120 conventional pharmaceutical excipients including Pharmaceutical Glycerin, Medicinal ....

    More
  • Finished Drugs Er Kang pharmaceutical owns 148 preparations in various forms, of which, the major products are Sulbenicillin Sodium for injection(all three specifications) and Compound Liquorice Tablets.

    More
  • APIs Er-Kang pharmaceutical owns 43 types of APIs, of which, the major products are Glycerin, Dilute Hydrochloric Acid, Dihydroxypropyl Theophylline, Sulbenicillin Sodium, Calamine Powder, Sulfadiazin....

    More
  • Talent
  • Care for
  • Honor
  • Product
  • Innovation
  • Employee
  • Shares
  • News
  • Talent
  • Care for